Signal active
Investment Firm
Overview
Ampersand is a product studio that develops tools to help creators grow their businesses.
Highlights
2021
Software
1-10
1
0
undefined
N/A
N/A
Location
United States, North America
Contact Information
Social
Profile Resume
Ampersand, established in 2021 and headquartered in United States, North America., specializes in investments across Biotechnology, Pharmaceutical, Developer Platform, Financial Services, Venture Capital, Finance, Health Care. Their recent investments include Victory Pharma, Essex Woodlands Healthcare Partners. The highest investment round they participated in was $2.0B. Among their most notable exits are Victory Pharma and Essex Woodlands Healthcare Partners. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
N/A
Investment portfolio
1
0
0
undefined
Investments
1
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Mar 09, 2009 | Victory Pharma | Biotechnology | 45.0M |
Exits
0
Funding Timeline
1
3
0
Funding Rounds
1
Ampersand has raised 1 rounds. Their latest funding was raised on Mar 09, 2009 from a Venture Round - Victory Pharma round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Mar 09, 2009 | Venture Round - Victory Pharma | - | 45.0M | - |
Investors
1
Ampersand is funded by 1 investor(s). El Cap Holdings Kantor is the most recent investors.
Investor Name | Lead Investor | Funding Round | Money Raised |
---|---|---|---|
El Cap Holdings | No | Pre Seed Round - Ampersand | 0 |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.